摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-环戊基-2-丙醇 | 1462-06-2

中文名称
2-环戊基-2-丙醇
中文别名
——
英文名称
1-cyclopentyl-1-methylethanol
英文别名
2-cyclopentyl-2-propanol;2-cyclopentyl-propan-2-ol;(α-Hydroxy-isopropyl)-cyclopentan;Dimethyl-cyclopentyl-carbinol;2-Methyl-2-cyclopentylaethan;Dimethyl-cyclopentylcarbinol;2-cyclopentylpropan-2-ol
2-环戊基-2-丙醇化学式
CAS
1462-06-2
化学式
C8H16O
mdl
MFCD07780533
分子量
128.214
InChiKey
PEYUSJVZHOLNDG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    77-78 °C(Press: 13 Torr)
  • 密度:
    0.9128 g/cm3

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2906199090

SDS

SDS:86eeee742ed02350a17f68f6885f6fae
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    酸催化内环和外环烯烃平衡的动力学
    摘要:
    已经测量了五元至八元环的酸催化的异亚丙基环烷烃异构化为异丙基环烯烃的平衡常数,该平衡常数是温度的函数。已从每种纯异构体开始测量了平衡速率。这些数据加在一起,可以为这些过程构造近似的能量图。将结果与类似系统上早期工作的结果进行比较和对比。
    DOI:
    10.1039/j29700001761
  • 作为产物:
    描述:
    6-methylhept-5-en-1-ol四氢呋喃 为溶剂, 反应 2.0h, 生成 2-环戊基-2-丙醇
    参考文献:
    名称:
    Olefinic Cyclizations. VI. Formolysis of Some Branched-Chain Alkenyl p-Nitrobenzenesulfonates
    摘要:
    DOI:
    10.1021/ja01078a037
点击查看最新优质反应信息

文献信息

  • FUSED HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTCIAL COMPOSITION, AND USES THEREOF
    申请人:SHANGHAI YINGLI PHARMACEUTICAL CO., LTD
    公开号:US20160244432A1
    公开(公告)日:2016-08-25
    Disclosed are a fused heterocyclic compound, a preparation method therefor, a pharmaceutical composition, and uses thereof. The fused heterocyclic compound is shown in formula I, formula II, or formula III. The preparation method of the fused heterocyclic compound and/or the pharmaceutically acceptable salt thereof in the present invention comprises three synthesizing routes. The present invention also provides a pharmaceutical composition of the fused heterocyclic compound, the pharmaceutical composition containing one or more of the fused heterocyclic compound shown in formula I, formula II, or formula III, the pharmaceutically acceptable salt thereof, hydrates, solvent compounds, polymorphs and prodrugs thereof, and a pharmaceutically acceptable carrier. The present invention also relates to an application of the fused heterocyclic compound and/or the pharmaceutical composition in preparing kinase inhibitors and in preparing drugs for preventing and treating diseases related to kinase. The fused heterocyclic compound of the present invention has selective inhibition function on PI3Kδ, and can be used for preparing drugs for preventing and treating cell proliferation diseases such as cancers, infections, inflammations, or autoimmune diseases.
    揭示了一种融合杂环化合物,其制备方法,药物组合物及其用途。所述融合杂环化合物如公式I、公式II或公式III所示。本发明的所述融合杂环化合物和/或其药用可接受盐的制备方法包括三种合成途径。本发明还提供了一种包含融合杂环化合物的药物组合物,所述药物组合物含有公式I、公式II或公式III所示的一个或多个融合杂环化合物,其药用可接受盐、水合物、溶剂化合物、多型体和前药,以及药用可接受载体。本发明还涉及应用所述融合杂环化合物和/或药物组合物制备激酶抑制剂以及制备用于预防和治疗与激酶相关疾病的药物。本发明的融合杂环化合物对PI3Kδ具有选择性抑制功能,可用于制备用于预防和治疗细胞增殖性疾病如癌症、感染、炎症或自身免疫疾病的药物。
  • TiCl<sub>4</sub> Induced Anti-Markovnikov Rearrangement
    作者:Mugio Nishizawa、Yumiko Asai、Hiroshi Imagawa
    DOI:10.1021/ol062337x
    日期:2006.12.1
    bicyclic tert-alcohols afforded identical ring-expansion products via cationic anti-Markovnikov rearrangement from perpendicular tert-cations into identical six-membered ring secondary cations by the treatment with TiCl4. These results provide evidence that the reaction takes place by the cationic stepwise mechanism. [reaction: see text]
    立体异构的双环叔醇通过用TiCl4处理,从垂直的叔阳离子转变为相同的六元环仲阳离子,通过阳离子抗马氏力重排而提供了相同的扩环产物。这些结果提供了反应是通过阳离子逐步机理进行的证据。[反应:看文字]
  • The kinetics of acid-catalysed equilibrations of endo- and exo-cyclic olefins
    作者:D. B. Bigley、R. W. May
    DOI:10.1039/j29700001761
    日期:——
    The equilibrium constants for the acid-catalysed isomerisation of isopropylidenecycloalkanes to isopropylcycloalkenes have been measured as a function of temperature for the five- to eight-membered rings. The rates of equilibration have been measured, starting from each pure isomer. Together these data permit the construction of approximate energy diagrams for the processes. The results are compared
    已经测量了五元至八元环的酸催化的异亚丙基环烷烃异构化为异丙基环烯烃的平衡常数,该平衡常数是温度的函数。已从每种纯异构体开始测量了平衡速率。这些数据加在一起,可以为这些过程构造近似的能量图。将结果与类似系统上早期工作的结果进行比较和对比。
  • Rearrangement Pathways of Five-Membered Ring Enlargement in Carbocations:  Quantum Chemical Calculations and Deuterium Kinetic Isotope Effects
    作者:Valerije Vrček、Martin Saunders、Olga Kronja
    DOI:10.1021/jo020694p
    日期:2003.3.1
    transition structure TS-II. Pathway III involves the uphill hydride shift and formation of the secondary cation 3, which undergoes Wagner-Meerwein 1,2-isopropyl shift via a transition structure TS-III and the protonated carbocation intermediate 4. The barrier pathway III is for 17.0 kcal/mol. Experimental secondary deuterium isotope effects of the rearrangement were measured for the hexadeuterated
    在平衡的2-环戊基-2-丙基和1-(2-丙基)环戊基阳离子1A / 1B中,五元环扩展的三个可能路线位于PES上,所有路径均在MP4 / 6-31G(d )// MP2 / 6-31G(d)的理论水平。在途径I中,六元过渡结构(TS-1)通过16.4 kcal / mol的势垒连接较不稳定的环戊基阳离子1A和1,2-二甲基环己基碳正离子(2)。在具有16.3 kcal / mol的势垒的途径II中,甲基迁移首先通过过渡结构TS-II在更稳定的1B中发生。途径III涉及上级氢化物的转移和二级阳离子3的形成,该次级阳离子3通过过渡结构TS-III和质子化的碳阳离子中间体4经历了瓦格纳-梅威因1,2-异丙基转移。屏障途径III的阻滞强度为17.0 kcal / mol 。通过1H NMR对六氘代1A-d6 / 1B-d6(kH / kD = 2.40)和四氘代1A-d4 / 1B-d4(kH /
  • Fungicides for the control of take-all disease of plants
    申请人:Monsanto Company
    公开号:US20010046975A1
    公开(公告)日:2001-11-29
    A method of controlling Take-all disease of plants by applying, preferably to the seed prior to planting, a fungicide of the formula 1 wherein Z 1 and Z 2 are C or N and are part of an aromatic ring selected from benzene, pyridine, thiophene, furan, pyrrole, pyrazole, thiazole, and isothiazole; A is selected from —C(X)-amine, —C(O)—SR 3 , —NH—C(X)R 4 , and —C(═NR )—XR 7 ; B is —W m —Q(R 2 ) 3 or selected from o-tolyl, 1-naphthyl, 2-naphthyl, and 9-phenanthryl, each optionally substituted with halogen or R 4 ; Q is C, Si, Ge, or Sn; W is —C(R 3 ) p H (2-p) —; or when Q is C, W is selected from —C(R 3 ) p H (2-p) —, —N(R 3 ) m H (1-m) —, —S(O) p —, and —O—; X is O or S; n is 0, 1, 2, or 3; m is 0 or 1; p is 0, 1, or 2; each R is independently selected from a) halo, formyl, cyano, amino, nitro, thiocyanato, isothiocyanato, trimethylsilyl, and hydroxy; b) C1-C4 alkyl, alkenyl, alkynyl, C3-C6 cycloalkyl, and cycloalkenyl, each optionally substituted with halo, hydroxy, thio, amino, nitro, cyano, formyl, phenyl, C1-C4 alkoxy, alkylcarbonyl, alkylthio, alkylamino, dialkylamino, alkoxycarbonyl, (alkylthio)carbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkylsulfinyl, or alkylsulfonyl; c) phenyl, furyl, thienyl, pyrrolyl, each optionally substituted with halo, formyl, cyano, amino, nitro, C1-C4 alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylamino, dialkylamino, haloalkyl, and haloalkenyl; d) C1-C4 alkoxy, alkenoxy, alkynoxy, C3-C6 cycloalkyloxy, cycloalkenyloxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, dialkylamino, alkylcarbonylamino, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkylcarbonyl, alkylcarbonyloxy, alkoxycarbonyl, (alkylthio)carbonyl, phenylcarbonylamino, phenylamino, each optionally substituted with halo; wherein two R groups may be combined to form a fused ring; each R 2 is independently selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl and phenyl, each optionally substituted with R 4 or halogen; and wherein, when Q is C, R 2 may also be selected from halo, alkoxy, alkylthio, alkylamino, and dialkylamino; wherein two R 2 groups may be combined to form a cyclo group with Q; R 3 is C1-C4 alkyl; R 4 is C1-C4 alkyl, haloalkyl, alkoxy, alkylthio, alkylamino, or dialkylamino; and R 7 is C1-C4 alkyl, haloalkyl, or phenyl, optionally substituted with halo, nitro, or R 4 ; or an agronomic salt thereof.
    通过在种子播种前,优选地向种子施用公式1的杀菌剂来控制植物的扁腐病,其中Z1和Z2是C或N,是从苯,吡啶,噻吩,呋喃,吡咯,吡唑,噻唑和异噻唑中选择的芳香环的一部分;A是从—C(X)-胺,—C(O)—SR3,—NH—C(X)R4和—C(═NR)—XR7中选择的;B是—Wm—Q(R2)3或从o-甲苯基,1-萘基,2-萘基和9-菲基中选择的,每个都可以用卤素或R4取代;Q是C,Si,Ge或Sn;W是—C(R3)pH(2-p)—;或当Q是C时,W从—C(R3)pH(2-p)—,—N(R3)mH(1-m)—,—S(O)p—和—O—中选择;X是O或S;n是0,1,2或3;m是0或1;p是0,1或2;每个R是独立选择的,从a)卤素,酰基,氰基,氨基,硝基,硫氰酸基,异硫氰酸基,三甲基硅基和羟基中选择;b)C1-C4烷基,烯基,炔基,C3-C6环烷基和环烯基,每个都可以用卤素,羟基,硫,氨基,硝基,氰基,酰基,苯基,C1-C4烷氧基,烷基羰基,烷基硫基,烷基氨基,二烷基氨基,烷氧羰基,(烷硫)羰基,烷基氨基羰基,二烷基氨基羰基,烷基亚砜基或烷基磺酰基取代;c)苯基,呋喃基,噻吩基,吡咯基,每个都可以用卤素,酰基,氰基,氨基,硝基,C1-C4烷基,烯基,炔基,烷氧基,烷基硫基,烷基氨基,二烷基氨基,卤代烷基和卤代烯基取代;d)C1-C4烷氧基,烯氧基,炔氧基,C3-C6环烷氧基,环烯氧基,烷基硫基,烷基亚砜基,烷基磺酰基,烷基氨基,二烷基氨基,烷基羰基氨基,氨基羰基,烷基氨基羰基,二烷基氨基羰基,烷基羰基,烷基羰氧基,烷氧羰基,(烷硫)羰基,苯基羰基氨基,苯基氨基,每个都可以用卤素取代;其中两个R基可以结合形成融合环;每个R2是独立选择的,从烷基,烯基,炔基,环烷基,环烯基和苯基中选择,每个都可以用R4或卤素取代;当Q为C时,R2还可以选择自卤素,烷氧基,烷基硫基,烷基氨基和二烷基氨基;其中两个R2基可以结合形成带有Q的环;R3是C1-C4烷基;R4是C1-C4烷基,卤代烷基,烷氧基,烷基硫基,烷基氨基或二烷基氨基;R7是C1-C4烷基,卤代烷基或苯基,可以选择自卤素,硝基或R4取代;或其农学盐。
查看更多